4.3 Article

The prognostic effect of the systemic immune-inflammation index on overall survival of periampullary cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Prognostic Factors in Resected Pancreatic Ductal Adenocarcinoma: Is Neutrophil-Lymphocyte Ratio a Useful Marker?

Ignacio Merlo et al.

Summary: This study found no association between neutrophil-lymphocyte ratio and overall survival after pancreatectomy. However, factors such as perineural invasion, surgical margins, CA19-9 level, and tumor size were associated with worse survival. Completion of adjuvant treatment was a protective factor.

JOURNAL OF GASTROINTESTINAL CANCER (2023)

Article Surgery

Prognostic Impact of Indicators of Systemic Inflammation and the Nutritional Status of Patients with Resected Carcinoma of the Ampulla of Vater: A Single-Center Retrospective Study

Yuji Shimizu et al.

Summary: High systemic inflammation index and malnutrition were identified as independent predictors of shorter overall survival in patients with resected ampulla of Vater carcinoma (AC).

WORLD JOURNAL OF SURGERY (2022)

Article Gastroenterology & Hepatology

Treatment and overall survival of four types of non- metastatic periampullary cancer: nationwide population- based cohort study

Evelien J. M. de Jong et al.

Summary: This retrospective study identified significant differences in treatment modalities and overall survival between the four origins of periampullary cancer. Improved overall survival after adjuvant chemotherapy could not be demonstrated in patients with ampullary cancer and duodenal adenocarcinoma.
Article Oncology

The role of systemic immuno-inflammatory factors in resectable pancreatic adenocarcinoma: a cohort retrospective

D. Schlanger et al.

Summary: This retrospective observational cohort study examined the impact of immune-inflammatory markers on the overall survival of patients with pancreatic ductal adenocarcinoma (PDAC) who underwent surgical resection. The results showed that postoperative lymphocyte count, platelet to lymphocyte ratio (PLR), and prognostic nutritional index (PNI) were factors influencing overall survival in PDAC patients.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

Article Gastroenterology & Hepatology

BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care

Alessandro Rizzo et al.

Summary: Biliary tract cancer is a heterogeneous group of aggressive malignancies with high recurrence rates post-surgery. Despite controversies in adjuvant treatment, capecitabine is gaining wide acceptance and may potentially become the standard care.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Oncology

Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade

Jin Shang et al.

Summary: Immune checkpoint blockade (ICB) therapy shows promising anti-tumor effects in pancreatic cancer, and changes in baseline SII and neutrophil-lymphocyte ratio (NLR) are important prognostic factors for patients, but their clinical utility requires further investigation in prospective studies.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer

Alessandro Bittoni et al.

Summary: Elevated systemic immune-inflammation index (SII) was found to be an independent negative prognostic factor for both overall survival (OS) and progression-free survival (PFS) in advanced pancreatic ductal adenocarcinoma (PDAC) patients undergoing first-line chemotherapy, highlighting the crucial role of systemic inflammation in PDAC progression and patient outcomes.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Surgery

Systemic immune-inflammation index as a prognostic marker for distal cholangiocarcinoma

Fumihiro Terasaki et al.

Summary: The systemic immune-inflammation index (SII) may be a useful prognostic marker for predicting the long-term survival in patients with distal cholangiocarcinoma (DCC) after pancreatoduodenectomy (PD). Patients with high SII levels (SII >= 1450) were independently associated with poor survival outcomes, along with other factors such as portal vein resection and microscopic venous invasion.

SURGERY TODAY (2021)

Review Oncology

Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges

Alessandro Rizzo et al.

Summary: Ampullary carcinomas are rare tumors with limited data on optimal treatment strategies, posing challenges for physicians. This review provides an overview of the biological and histological characteristics of AC, as well as available data guiding current and future therapeutic strategies.

CURRENT ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection

Gerd Jomrich et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2020)

Article Endocrinology & Metabolism

Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms

Wentao Zhou et al.

ENDOCRINE CONNECTIONS (2020)

Article Medicine, Research & Experimental

Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer

Ke Zhang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Review Oncology

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma

Etienne Buscail et al.

CANCERS (2019)

Article Gastroenterology & Hepatology

Systemic immune-inflammation index for predicting prognosis of colorectal cancer

Jian-Hui Chen et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Review Cell Biology

Cancer and Thrombosis: The Platelet Perspective

Claire K. S. Meikle et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)

Article Multidisciplinary Sciences

Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

Diletta Di Mitri et al.

NATURE (2014)

Article Immunology

Cancer-Related Inflammation

Juliana Candido et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2013)

Review Medicine, General & Internal

Inflammation and cancer: back to Virchow?

F Balkwill et al.

LANCET (2001)